387 related articles for article (PubMed ID: 10229238)
1. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
Parman T; Wiley MJ; Wells PG
Nat Med; 1999 May; 5(5):582-5. PubMed ID: 10229238
[TBL] [Abstract][Full Text] [Related]
2. In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis.
Liu L; Wells PG
Toxicol Appl Pharmacol; 1994 Apr; 125(2):247-55. PubMed ID: 8171432
[TBL] [Abstract][Full Text] [Related]
3. Oxidative damage in chemical teratogenesis.
Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM
Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860
[TBL] [Abstract][Full Text] [Related]
4. Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism.
Lee CJ; Gonçalves LL; Wells PG
FASEB J; 2011 Jul; 25(7):2468-83. PubMed ID: 21502285
[TBL] [Abstract][Full Text] [Related]
5. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant.
Liu L; Wells PG
Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459
[TBL] [Abstract][Full Text] [Related]
6. Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species.
Wells PG; Bhuller Y; Chen CS; Jeng W; Kasapinovic S; Kennedy JC; Kim PM; Laposa RR; McCallum GP; Nicol CJ; Parman T; Wiley MJ; Wong AW
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):354-66. PubMed ID: 16081118
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate.
Arlen RR; Wells PG
J Pharmacol Exp Ther; 1996 Jun; 277(3):1649-58. PubMed ID: 8667234
[TBL] [Abstract][Full Text] [Related]
8. DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects: phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2'-deoxyguanosine in vitro and in vivo in murine maternal hepatic and embryonic tissues.
Liu L; Wells PG
Free Radic Biol Med; 1995 Nov; 19(5):639-48. PubMed ID: 8529923
[TBL] [Abstract][Full Text] [Related]
9. Biochemical toxicology of chemical teratogenesis.
Wells PG; Winn LM
Crit Rev Biochem Mol Biol; 1996 Feb; 31(1):1-40. PubMed ID: 8744954
[TBL] [Abstract][Full Text] [Related]
10. A role for glutathione, independent of oxidative stress, in the developmental toxicity of methanol.
Siu MT; Shapiro AM; Wiley MJ; Wells PG
Toxicol Appl Pharmacol; 2013 Dec; 273(3):508-15. PubMed ID: 24095963
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin H synthase-catalyzed bioactivation of amphetamines to free radical intermediates that cause CNS regional DNA oxidation and nerve terminal degeneration.
Jeng W; Ramkissoon A; Parman T; Wells PG
FASEB J; 2006 Apr; 20(6):638-50. PubMed ID: 16581972
[TBL] [Abstract][Full Text] [Related]
12. Receptor- and reactive intermediate-mediated mechanisms of teratogenesis.
Wells PG; Lee CJ; McCallum GP; Perstin J; Harper PA
Handb Exp Pharmacol; 2010; (196):131-62. PubMed ID: 20020262
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin H synthase-1-catalyzed bioactivation of neurotransmitters, their precursors, and metabolites: oxidative DNA damage and electron spin resonance spectroscopy studies.
Gonçalves LL; Ramkissoon A; Wells PG
Chem Res Toxicol; 2009 May; 22(5):842-52. PubMed ID: 19374330
[TBL] [Abstract][Full Text] [Related]
14. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.
Wells PG; Zubovits JT; Wong ST; Molinari LM; Ali S
Toxicol Appl Pharmacol; 1989 Feb; 97(2):192-202. PubMed ID: 2493687
[TBL] [Abstract][Full Text] [Related]
15. A novel hypothesis for thalidomide-induced limb teratogenesis: redox misregulation of the NF-kappaB pathway.
Hansen JM; Harris C
Antioxid Redox Signal; 2004 Feb; 6(1):1-14. PubMed ID: 14713331
[TBL] [Abstract][Full Text] [Related]
16. Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
Winn LM; Wells PG
Mol Pharmacol; 1995 Jul; 48(1):112-20. PubMed ID: 7623765
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer.
Wells PG; McCallum GP; Chen CS; Henderson JT; Lee CJ; Perstin J; Preston TJ; Wiley MJ; Wong AW
Toxicol Sci; 2009 Mar; 108(1):4-18. PubMed ID: 19126598
[TBL] [Abstract][Full Text] [Related]
18. Protective role of alpha-phenyl-N-t-butylnitrone against ionizing radiation in U937 cells and mice.
Lee JH; Park JW
Cancer Res; 2003 Oct; 63(20):6885-93. PubMed ID: 14583487
[TBL] [Abstract][Full Text] [Related]
19. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis.
Winn LM; Wells PG
Free Radic Biol Med; 1997; 22(4):607-21. PubMed ID: 9013124
[TBL] [Abstract][Full Text] [Related]
20. D-mannitol, a specific hydroxyl free radical scavenger, reduces the developmental toxicity of hydroxyurea in rabbits.
Desesso JM; Scialli AR; Goeringer GC
Teratology; 1994 Apr; 49(4):248-59. PubMed ID: 8073363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
